Literature DB >> 18408248

Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative.

D J Hunter1, J Niu, Y Zhang, S Totterman, J Tamez, C Dabrowski, R Davies, M-P Hellio Le Graverand, M Luchi, Y Tymofyeyev, C R Beals.   

Abstract

OBJECTIVE: The performance characteristics of hyaline articular cartilage measurement on magnetic resonance imaging (MRI) need to be accurately delineated before widespread application of this technology. Our objective was to assess the rate of natural disease progression of cartilage morphometry measures from baseline to 1 year in knees with osteoarthritis (OA) from a subset of participants from the Osteoarthritis Initiative (OAI).
METHODS: Subjects included for this exploratory analysis are a subset of the approximately 4700 participants in the OAI Study. Bilateral radiographs and 3T MRI (Siemans Trio) of the knees and clinical data were obtained at baseline and annually in all participants. 160 subjects from the OAI Progression subcohort all of whom had both frequent symptoms and, in the same knee, radiographic OA based on a screening reading done at the OAI clinics were eligible for this exploratory analysis. One knee from each subject was selected for analysis. 150 participants were included. Using sagittal 3D DESSwe (double echo, steady-state sequence with water excitation) MR images from the baseline and 12 follow-up month visit, a segmentation algorithm was applied to the cartilage plates of the index knee to compute the cartilage volume, normalised cartilage volume (volume normalised to bone surface interface area), and percentage denuded area (total cartilage bone interface area denuded of cartilage).
RESULTS: Summary statistics of the changes (absolute and percentage) from baseline at 1 year and the standardised response mean (SRM), ie, mean change divided by the SD change were calculated. On average the subjects were 60.9 years of age and obese, with a mean body mass index of 30.3 kg/m2. The SRMs for cartilage volume of various locations are: central medial tibia -0.096; central medial femur -0.394; and patella -0.198. The SRMs for normalised cartilage volume of the various locations are central medial tibia -0.044, central medial femur -0.338 and patella -0.193. The majority of participants had a denuded area at baseline in the central medial femur (62%) and central medial tibia (60%). In general, the SRMs were small.
CONCLUSIONS: These descriptive results of cartilage morphometry and its change at the 1-year time point from the first substantive MRI data release from the OAI Progression subcohort indicate that the annualised rates of change are small with the central medial femur showing the greatest consistent change.

Entities:  

Mesh:

Year:  2008        PMID: 18408248      PMCID: PMC2734969          DOI: 10.1136/ard.2007.082107

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Prevalence of disabilities and associated health conditions among adults--United States, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-02-23       Impact factor: 17.586

2.  The role of knee alignment in disease progression and functional decline in knee osteoarthritis.

Authors:  L Sharma; J Song; D T Felson; S Cahue; E Shamiyeh; D D Dunlop
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Permeability of articular cartilage.

Authors:  A Maroudas; P Bullough
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

4.  Tibial and femoral cartilage changes in knee osteoarthritis.

Authors:  F M Cicuttini; A E Wluka; S L Stuckey
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

5.  Arthritis prevalence and activity limitations in older adults.

Authors:  D D Dunlop; L M Manheim; J Song; R W Chang
Journal:  Arthritis Rheum       Date:  2001-01

6.  Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility.

Authors:  C Peterfy; J Li; S Zaim; J Duryea; J Lynch; Y Miaux; W Yu; H K Genant
Journal:  Skeletal Radiol       Date:  2003-02-06       Impact factor: 2.199

7.  The determinants of change in tibial cartilage volume in osteoarthritic knees.

Authors:  Anita E Wluka; Stephen Stuckey; Judith Snaddon; Flavia M Cicuttini
Journal:  Arthritis Rheum       Date:  2002-08

8.  Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis.

Authors:  C G Peterfy; A Guermazi; S Zaim; P F J Tirman; Y Miaux; D White; M Kothari; Y Lu; K Fye; S Zhao; H K Genant
Journal:  Osteoarthritis Cartilage       Date:  2004-03       Impact factor: 6.576

9.  Atlas of individual radiographic features in osteoarthritis.

Authors:  R D Altman; M Hochberg; W A Murphy; F Wolfe; M Lequesne
Journal:  Osteoarthritis Cartilage       Date:  1995-09       Impact factor: 6.576

10.  Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging: technical validation for use in analysis of cartilage volume and further morphologic parameters.

Authors:  Heiko Graichen; Rüdiger von Eisenhart-Rothe; Thomas Vogl; Karl-Hans Englmeier; Felix Eckstein
Journal:  Arthritis Rheum       Date:  2004-03
View more
  45 in total

Review 1.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

2.  Comparison of 1-year vs 2-year change in regional cartilage thickness in osteoarthritis results from 346 participants from the Osteoarthritis Initiative.

Authors:  W Wirth; S Larroque; R Y Davies; M Nevitt; A Gimona; F Baribaud; J H Lee; O Benichou; B T Wyman; M Hudelmaier; S Maschek; F Eckstein
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

3.  Use magnetic resonance imaging to assess articular cartilage.

Authors:  Yuanyuan Wang; Anita E Wluka; Graeme Jones; Changhai Ding; Flavia M Cicuttini
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

4.  Presence, location, type and size of denuded areas of subchondral bone in the knee as a function of radiographic stage of OA - data from the OA initiative.

Authors:  R B Frobell; W Wirth; M Nevitt; B T Wyman; O Benichou; D Dreher; R Y Davies; J H Lee; F Baribaud; A Gimona; M Hudelmaier; S Cotofana; F Eckstein
Journal:  Osteoarthritis Cartilage       Date:  2010-02-06       Impact factor: 6.576

5.  Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects.

Authors:  David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

6.  Magnetic resonance imaging evaluation of weight-bearing subchondral trabecular bone in the knee.

Authors:  Erika Schneider; Grace H Lo; Gretchen Sloane; Lynn Fanella; David J Hunter; Charles B Eaton; Timothy E McAlindon
Journal:  Skeletal Radiol       Date:  2010-05-07       Impact factor: 2.199

7.  The Osteoarthritis Initiative (OAI) magnetic resonance imaging quality assurance update.

Authors:  E Schneider; M Nessaiver
Journal:  Osteoarthritis Cartilage       Date:  2012-10-23       Impact factor: 6.576

8.  The relation of femoral notch stenosis to ACL tears in persons with knee osteoarthritis.

Authors:  V Stein; L Li; A Guermazi; Y Zhang; C Kent Kwoh; C B Eaton; D J Hunter
Journal:  Osteoarthritis Cartilage       Date:  2009-10-02       Impact factor: 6.576

Review 9.  The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee.

Authors:  C G Peterfy; E Schneider; M Nevitt
Journal:  Osteoarthritis Cartilage       Date:  2008-09-10       Impact factor: 6.576

10.  Relationship of compartment-specific structural knee status at baseline with change in cartilage morphology: a prospective observational study using data from the osteoarthritis initiative.

Authors:  Felix Eckstein; Wolfgang Wirth; Martin I Hudelmaier; Susanne Maschek; Wolfgang Hitzl; Bradley T Wyman; Michael Nevitt; Marie-Pierre Hellio Le Graverand; David Hunter
Journal:  Arthritis Res Ther       Date:  2009-06-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.